Tariffs, DOGE layoffs, and immigration are the combined forces currently worrying Wall Street. President Donald Trump’s ...

U.S. President Donald Trump's decision to impose tariffs is part of a plan to "level the playing field" that he views as ...

US stocks slid Monday as investors braced for President Donald Trump’s proposed tariffs on Canada and Mexico to go into effect by the midnight deadline.

Shares of industrial and transportation companies fell Monday amid growing concerns that the U.S. economy could be slowing faster than previously thought. Goldman Sachs analysts warned that tariffs ...

A former Main Line businessman allegedly committed a fraud scheme involving the misuse of investor proceeds and taking ...

Gold futures rebounded to nearly $2,900/oz after last week’s sharp correction, as investors weighed the economic implications ...

Saudi Arabia's sovereign wealth fund will be the anchor investor in Goldman Sachs Asset Management's specific new funds ...

European equities have outperformed U.S. stocks by the widest margin since 2000 amid optimism about a stabilizing economy, and the prospect of increased fiscal stimulus and an end to war in Ukraine.

Saudi Arabia’s Public Investment Fund is set to become an anchor investor in a series of new funds from Goldman Sachs Asset ...

Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.

Goldman Sachs is among Wall Street firms that have been expanding their presence in Saudi Arabia as the kingdom looks to ...